tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO

BridgeBio Pharma (BBIO) Revenue

Compare
1,174 Followers

BridgeBio Pharma Revenue

BridgeBio Pharma had a revenue of 116.63M in the quarter ending Mar 31, 2025, with 1882.88%. This bring the company's revenue in the last twelve months to 127.42M, Increased -42.58%. In the fiscal year ending Dec 31, 2024, BridgeBio Pharma had annual revenue of 221.90M with 2285.27% growth.
Revenue (ttm)
127.42M
Revenue Growth
-41.71%
P/S Ratio
31.61
Revenue/Employee
$306,072
Employees
725
Market Cap
$7.01B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024221.90M212.60M+2,285.27%
Dec 31, 20239.30M-68.34M-88.02%
Dec 31, 202277.65M7.93M+11.38%
Dec 31, 202169.72M61.47M+745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 201940.56M+∞%
Dec 31, 20180.00
Dec 31, 20170.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis